Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma

Gemcitabine has high activity against nasopharyngeal carcinoma (NPC). The level of ribonucleotide reductase subunit M1 (RRM1) expression is closely related to the efficacy of gemcitabine on non-small cell lung cancer and pancreatic cancer. However, the expression of RRM1 and its association with sen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhao, Li-Ping, Xue, Cong, Zhang, Jian-Wei, Hu, Zhi-Huang, Zhao, Yuan-Yuan, Zhang, Jing, Huang, Yan, Zhao, Hong-Yun, Zhang, Li
Format: Artigo
Idioma:Inglês
Publicat: Sun Yat-sen University Cancer Center 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3777452/
https://ncbi.nlm.nih.gov/pubmed/22692073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.012.10029
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars